Accutar Biotechnology Inc. — Form D
Accutar Biotechnology Inc. of Brooklyn, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-02. $20.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-09-02
- Form: D
- Accession: 0001783798-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $20.0M
- Investors: 1
- Date of first sale: 2020-08-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-374661
Issuer
- Name: Accutar Biotechnology Inc.
- CIK: 0001783798
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 760 Parkside Avenue, Suite 213, Brooklyn, NY, 11226
- Phone: 646-462-5083
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Jie FAN | Director | Cranbury, NJ |
| Jie FAN | Executive Officer | Cranbury, NJ |
| Quan ZHOU | Director | Rockville, MD |
| Wei He | Executive Officer | Brooklyn, NY |
| Ling Zou | Director | Brooklyn, NY |
| Xiangyan Sun | Executive Officer | Brooklyn, NY |
| Yimin Qian | Executive Officer | Brooklyn, NY |
| Ke Liu | Executive Officer | Brooklyn, NY |
| Long Zhu | Director | Brooklyn, NY |
Other filings by this issuer (2)
More